Back
Intellia Therapeutics Stock Price Chart
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
1
NTLA
Intellia Therapeutics
Last Price:
$6.64
Seasonality Move:
25.88%
7 Day Trial
ALL ACCESS PASS
$
7
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing slight selling pressure.
Intellia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.68 | Sell |
| 20-day SMA: | 8.7 | Sell |
| 50-day SMA: | 9.71 | Sell |
| 200-day SMA: | 16.76 | Sell |
| 8-day EMA: | 7.6 | Sell |
| 20-day EMA: | 8.47 | Sell |
| 50-day EMA: | 9.74 | Sell |
| 200-day EMA: | 15.74 | Sell |
Intellia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.81 | Sell |
| Relative Strength Index (14 RSI): | 33.24 | Sell |
| Chaikin Money Flow: | -1768176 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Intellia Therapeutics Technical Analysis
| Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics Stock
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 6.89 while NTLA 8-day simple moving average is 7.68, which is a Sell signal.
-
The stock price of NTLA is 6.89 while Intellia Therapeutics 20-day SMA is 8.70, which makes it a Sell.
-
Intellia Therapeutics 50-day simple moving average is 9.71 while NTLA share price is 6.89, making it a Sell technically.
-
NTLA stock price is 6.89 and Intellia Therapeutics 200-day simple moving average is 16.76, creating a Sell signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
1
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy or a Sell?
-
Intellia Therapeutics stock is rated a SellThe current Intellia Therapeutics [NTLA] share price is $6.89. The Score for NTLA is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics Stock Info
Market Cap:
713.2M
Price in USD:
6.89
Share Volume:
3.9M
Intellia Therapeutics 52-Week Range
52-Week High:
28.18
52-Week Low:
6.50
Sell
1
Intellia Therapeutics (NTLA)
is a Sell
Intellia Therapeutics Share Price Forecast
-
What is the Intellia Therapeutics stock price today?The Intellia Therapeutics stock price is 6.89 USD today.
-
Will NTLA stock go up or go down?Intellia Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Intellia Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics is overvalued.
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 6.89 while NTLA 8-day exponential moving average is 7.60, which is a Sell signal.
-
The stock price of NTLA is 6.89 while Intellia Therapeutics 20-day EMA is 8.47, which makes it a Sell.
-
Intellia Therapeutics 50-day exponential moving average is 9.74 while NTLA share price is 6.89, making it a Sell technically.
-
NTLA stock price is 6.89 and Intellia Therapeutics 200-day simple moving average is 15.74, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics
Is Intellia Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.49 per share, and an increase next year of $0.27 per share.
Technical Analysis of Intellia Therapeutics
Should I short Intellia Therapeutics stock?
-
NTLA Moving Average Covergence Divergence (MACD) indicator is -0.81, suggesting Intellia Therapeutics is a Sell
-
Intellia Therapeutics Relative Strength Index (RSI) is 33.24, which suggest Intellia Therapeutics is oversold
-
The Bollinger Bands (25) for Intellia Therapeutics is ( - ), which suggest Intellia Therapeutics is a Buy
-
The Bollinger Bands (100) for Intellia Therapeutics is ( - ), which suggest Intellia Therapeutics is a Buy
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.